Glycopeptid-resistant Enterococcus outbreak in an ICU with simultaneous circulation of two different clones;Épidémie en réanimation médicochirurgicale d'Enterococcus faecium résistants aux glycopeptides (ERG) avec cocirculation de deux clones différents

Pathologie Biologie

Volumn 56, Issue 7-8, 2008, Pages 454-460

  Delamare, C ^a   Lameloise, V ^b   Lozniewski, A ^c   Perrin, M ^a   Baudin, C ^b   Sellies, J ^b   Dumay, M ^b   Bemer, M ^b  

^a Hopital Bel Air CHR Metz   (France)

^b Centre Hospitalier Regional Metz Thionville   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Enterococcus; Epidemy; Fecal carriage; Glycopeptides resistant; Intensive care unit; Nosocomial

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; COTRIMOXAZOLE; GLYCOPEPTIDE; IMIPENEM; QUINOLONE DERIVATIVE; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CARRIER; BACTERIUM COLONY; BACTERIUM ISOLATE; BACTERIUM ISOLATION; DATA ANALYSIS; DISEASE CONTROL; ENTEROCOCCUS; EPIDEMIC; GENOTYPE; HEMODIALYSIS; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; MOLECULAR CLONING; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; AGED; ANTIBIOTIC RESISTANCE; CELL CLONE; COMMUNICABLE DISEASE; COMPARATIVE STUDY; CROSS INFECTION; DRUG EFFECT; ENTEROCOCCUS FAECIUM; FRANCE; GENETICS; GRAM POSITIVE INFECTION; HETEROZYGOTE; HOSPITAL; HOSPITAL SUBDIVISIONS AND COMPONENTS; INFECTION CONTROL; ISOLATION AND PURIFICATION; MASS SCREENING; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; RECTUM; UNIVERSITY HOSPITAL;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CARRIER STATE; CLONE CELLS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS FAECIUM; FRANCE; GLYCOPEPTIDES; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITAL UNITS; HOSPITALS, UNIVERSITY; HOSPITALS, URBAN; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; MASS SCREENING; MIDDLE AGED; RECTUM;

EID: 56949091951     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2008.07.034     Document Type: Article

References (29)

1. Leclercq R., Derlot E., Duval J., and Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 319 3 (1988) 157-161
2. Anne H, Uttley C, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988;1(8575-6):57-8.
3. Cetinkaya Y., Falk P., and Mayhall C.G. Vancomycin-resistant enterococci. Clin Microbiol Rev 13 (2000) 686-707
4. Woodford N. Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci. Microb Drug Resist 7 (2001) 229-234
5. Arthur M., Molinas C., Depardieu F., and Courvalin P. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 175 1 (1993) 117-127
6. Zhanel G.G., DeCorby M., Laing N., Weshnoweski B., Vashisht R., Tailor F., et al., Canadian Antimicrobial Resistance Alliance (CARA). Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrob Agents Chemother 52 4 (2008) 1430-1437
7. Naas T., Fortineau N., Snanoudj R., Spicq C., Durrbach A., and Nordmann P. First nosocomial outbreak of vancomycin-resistant Enterococcus faecium expressing a VanD-like phenotype associated with a vanA genotype. J Clin Microbiol 43 (2005) 3642-3649
8. Bonten M.J.M., Willems R., and Weinstein R.A. Vancomycin-resistant enterococci: why are they here and where do they come from?. Lancet Infect Dis 1 (2001)
9. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin-United States, 1989-1993. MMWR Morb Mortal Wkly Rep 42 30 (1993) 597-599
10. Low D.E., Keller N., Barth A., and Jones R.N. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 32 (2001) S133-S145
11. National Nosocomial Infections Surveillance (NNIS) System Report. Data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470-85.
12. European Antimicrobial Resistance Surveillance System (EARSS). Données 2004. Données françaises des réseaux ONERBA Azay-Résistance, ColBVH,. Île de France; 2004.
13. Lee K., Kim Y.A., Park Y.J., Lee H.S., Kim M.Y., Kim E.C., et al., Korean Natiowide Surveillance of Antimicrobial Resistance Group. Increasing prevalence of vancomycin-resistant enterococci, and cefoxitin-, imipenem- and fluoroquinolone-resistant Gram-negative bacilli: a KONSAR study in 2002. Yonsei Med J 45 4 (2004) 598-608
14. Titze-de-Almeida R., Van Belkum A., Felipe M.S., Zanella R.C., Top J., and Willems R.J. Multilocus sequence typing of hospital-associated Enterococcus faecium from Brazil reveals their unique evolutionary history. Microb Drug Resist 12 2 (2006) 121
15. Trystram D, Varon E, Péan Y, Grundmann H, Gutmann L, Jarlier V, et al. Réseau européen de surveillance de la résistance bactérienne aux antibiotiques (EARSS) : résultats 2002, place de la France. Bull Epidemiol Hebd 2004;2-33:142-4.
16. Leclercq R, et al. Les entérocoques résistants à la vancomycine : situation en France en 2005. Avis du comité technique des infections nosocomiales et des infections liées aux soins relatifs à la maîtrise de la diffusion des entérocoques résistants aux glycopeptides dans les établissements de santé français. Bull Epidemiol Hebd 2006;13:85-9.
17. Lesens O., Robin F., Corbin V., et al. Vancomycin-resistant Enterococcus in an epidemic situation: screening at admission for patients at risk of carriage. Presse Med 35 (2006) 1167-1173
18. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 33 9 (1995) 2233-2239
19. Godreuil S., Marchandin H., Boulier A., Boumzebra A., Campos J., and Jean-Pierre H. A 6-year study of glycopeptides-resistant enterococci in 3 intensive care units of the University Hospital of Montpellier. Pathol Biol 55 8-9 (2007) 418-423
20. Lambiase A., Del Pezzo M., Piazza O., Petagna C., De Luca C., and Rossano F. Typing of vancomycin-resistant Enterococcus faecium strains in a cohort of patients in an Italian intensive care unit. Infection 35 6 (2007) 428-433
21. Peta M., Carretto E., Barbarini D., Zamperoni A., Carnevale L., Perversi L., et al. Outbreak of vancomycin-resistant Enterococcus spp. in an Italian general intensive care unit. Clin Microbiol Infect 12 2 (2006) 163-169
22. Talon D., Bertrand X., and Thouverez M. Facteurs de risque et prévention de l'acquisition et de la transmission des entérocoques résistants aux glycopeptides. Pathol Biol 49 (2001) 641-648
23. Lautenbach E., Bilker W.B., and Brennan P.J. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol 20 (1999) 318-323
24. Linden P.K., Pasculle A.W., Manez R., Kramer D.J., Fung J.J., Pinna A.D., et al. Differences in outcomes for patients with bactermia due to vancomycin-resistant Enterococcus faecium or vancomycinsusceptible E. faecium. Clin Infect Dis 22 (1996) 663-670
25. Avis du Comité technique des infections nosocomiales et des infections liées aux soins relatif à la maîtrise de la diffusion des entérocoques résistants aux glycopeptides dans les établissements de santé français, 6 octobre 2005. Bull Epidemiol Hebd 2006;13:88-9.
26. Muto C.A., Jernigan J.A., Ostrowsky B.E., et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 24 (2003) 362-386
27. Barrett S.P. Debate-guidelines for GRE control-the case for optimism. J Hosp Infect 57 4 (2004) 285-289
28. Lucet J.C., Armand-Lefevre L., Laurichesse J.J., Macrez A., Papy E., Ruimy R., et al. Rapid control of an outbreak of vancomycin-resistant enterococci in a French university hospital. J Hosp Infect 67 1 (2007) 42-48
29. Handwerger S., Raucher B., Altarac D., Monka J., Marchione S., Singh K.V., et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 16 6 (1993) 750-755